Integra LifeSciences, a leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. Integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. In the United States, Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. 
Type
Public
HQ
Plainsboro Center, US
Size (employees)
3,700 (est)
Integra LifeSciences is headquartered in Plainsboro Center, US
Report incorrect company information

Integra LifeSciences Office Locations

Integra LifeSciences has offices in Memphis, West Valley City, Plainsboro Center, Oakville and in 2 other locations
Plainsboro Center, US (HQ)
311 Enterprise Dr
Billerica, US
85 Rangeway Rd
Memphis, US
107 7740 Trinity Rd
West Valley City, US
3498 W 2400 S
York, US
3670 Concord Road
Oakville, CA
2590 Bristol Cir
Show all (6)
Report incorrect company information

Integra LifeSciences Financials and Metrics

Integra LifeSciences Financials

Integra LifeSciences's revenue was reported to be $1.19 b in FY, 2017
USD

Revenue (Q1, 2018)

357.1 m

Gross profit (Q1, 2018)

212.9 m

Gross profit margin (Q1, 2018), %

59.6%

Net income (Q1, 2018)

11 m

EBIT (Q1, 2018)

25.6 m

Market capitalization (15-May-2018)

5.2 b

Closing share price (15-May-2018)

63.2

Cash (31-Mar-2018)

189.4 m
Integra LifeSciences's current market capitalization is $5.2 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

836.2 m928.3 m882.7 m992.1 m1.2 b

Revenue growth, %

11%(5%)12%

Cost of goods sold

334.1 m352.8 m326.5 m349.1 m435.5 m

Gross profit

502.1 m575.5 m556.2 m643 m752.7 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

213.2 m215.1 m231.4 m229.7 m233.7 m244.1 m226.4 m236.8 m249.3 m250.3 m258.6 m282.2 m278.8 m357.1 m

Cost of goods sold

84.1 m82.4 m87 m86 m86.7 m86.5 m86.1 m84.8 m89.6 m89.3 m86.6 m99 m101.8 m144.2 m

Gross profit

129.1 m132.7 m144.4 m143.7 m146.9 m157.5 m140.3 m152 m159.7 m161 m172.1 m183.2 m177.1 m212.9 m

Gross profit Margin, %

61%62%62%63%63%65%62%64%64%64%67%65%64%60%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

120.6 m72 m48.1 m102.1 m174.9 m

Accounts Receivable

Inventories

26.8 m29.6 m42.6 m217.3 m296.3 m

Current Assets

525.2 m529.3 m438.5 m495.2 m822.1 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

118.9 m129 m137.2 m140.2 m79.9 m131.3 m79.3 m77.1 m86.8 m107.6 m124.1 m154.6 m481.9 m189.4 m

Inventories

207.4 m215.2 m223.6 m230.5 m233 m241.8 m213.9 m222 m220.4 m219.7 m239.8 m234.7 m232.3 m290.5 m

Current Assets

510.6 m539.7 m564.2 m562.6 m522 m608.2 m504.9 m494.6 m494 m511.9 m568.9 m616.2 m944.9 m848.7 m

PP&E

192.7 m205.7 m206.7 m203.9 m210.1 m215.5 m197.2 m210.3 m208.6 m212.2 m229.1 m232.1 m232.2 m274 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(17 m)34 m(3.5 m)74.6 m64.7 m

Depreciation and Amortization

47 m61.1 m58.9 m72.7 m88.9 m

Inventories

(42 m)(27 m)(3.8 m)(9.6 m)99 k

Accounts Payable

Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(28.6 m)2.2 m4.8 m9.8 m8.4 m5 m(31.9 m)11.6 m12.8 m20.1 m6.4 m11 m

Depreciation and Amortization

27.1 m

Inventories

1.3 m

Cash From Operating Activities

41.5 m
USDY, 2018

Financial Leverage

3.3 x
Show all financial metrics
Report incorrect company information